Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening

doi:10.3748/wjg.14.524

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5734)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

477

HTML

4717

Figures (1-4)

291

Tables (1-2)

249

Sum=5734

Jan 28, 2008 (publication date) through Jan 17, 2025

Times Cited of This Article

Times Cited (83)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Jan 28, 2008; 14(4): 524-531
Published online Jan 28, 2008. doi: 10.3748/wjg.14.524

Full Size Figure Download Figure

Figure 3 Prevalence of hypermethylated SFRP2 in stool and tissue specimens taken from the subjects with normal colonic mucosa, hyperplastic polyps (HP), adenomas and colorectal cancers (CRCs).

Citation: Wang DR, Tang D. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol 2008; 14(4): 524-531
URL: https://www.wjgnet.com/1007-9327/full/v14/i4/524.htm
DOI: https://dx.doi.org/10.3748/wjg.14.524